News
Dr. Melinda Cail from Primary Health Partners joins us in the KFOR Studios on Thursday afternoon to discuss Parkinson's disease.
The Phase I trial of ENERGI-F705PD tablet was a randomized, double-blind, placebo-controlled study designed to evaluate the safety, tolerability, and ...
Long-term cycling programs appear to reshape brain signals in Parkinson’s patients Deep brain stimulation recordings reveal ...
Yet, under federal law, it is labeled "rare" because that definition is based on prevalence —a static snapshot of how many ...
UCB emerged as a major biopharmaceutical player in the 1990s with the development of blockbuster drugs Zyrtec and Keppra. Throughout the 1990s and early 2000s, UCB transformed from a hybrid ...
Rosemary has long been linked to memory. In Shakespeare’s Hamlet, the character Ophelia says, “There’s rosemary, that’s for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results